60 Degrees Pharmaceuticals (60 Degrees Pharmaceuticals) Cash-to-Debt : 12.45 (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is 60 Degrees Pharmaceuticals Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. 60 Degrees Pharmaceuticals's cash to debt ratio for the quarter that ended in Dec. 2023 was 12.45.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, 60 Degrees Pharmaceuticals could pay off its debt using the cash in hand for the quarter that ended in Dec. 2023.

The historical rank and industry rank for 60 Degrees Pharmaceuticals's Cash-to-Debt or its related term are showing as below:

SXTPW' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.01 Med: 0.01 Max: 12.45
Current: 12.45

During the past 4 years, 60 Degrees Pharmaceuticals's highest Cash to Debt Ratio was 12.45. The lowest was 0.01. And the median was 0.01.

SXTPW's Cash-to-Debt is ranked better than
59.19% of 1539 companies
in the Biotechnology industry
Industry Median: 6.51 vs SXTPW: 12.45

60 Degrees Pharmaceuticals Cash-to-Debt Historical Data

The historical data trend for 60 Degrees Pharmaceuticals's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

60 Degrees Pharmaceuticals Cash-to-Debt Chart

60 Degrees Pharmaceuticals Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Cash-to-Debt

0.01

12.45

60 Degrees Pharmaceuticals Quarterly Data
	Dec20	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Cash-to-Debt	Get a 7-Day Free Trial						0.01	-	-	11.74	12.45

Competitive Comparison of 60 Degrees Pharmaceuticals's Cash-to-Debt

For the Biotechnology subindustry, 60 Degrees Pharmaceuticals's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

60 Degrees Pharmaceuticals's Cash-to-Debt Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 60 Degrees Pharmaceuticals's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where 60 Degrees Pharmaceuticals's Cash-to-Debt falls into.

60 Degrees Pharmaceuticals Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

60 Degrees Pharmaceuticals's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	2.142	/	(0.022	+	0.15)
	=	12.45

60 Degrees Pharmaceuticals's Cash to Debt Ratio for the quarter that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	2.142	/	(0.022	+	0.15)
	=	12.45

60 Degrees Pharmaceuticals (NAS:SXTPW) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

60 Degrees Pharmaceuticals Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of 60 Degrees Pharmaceuticals's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

60 Degrees Pharmaceuticals (60 Degrees Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 60 Degrees Pharmaceuticals Inc (NAS:SXTPW) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

SXTP:USA

Address

1025 Connecticut Avenue NW, Suite 1000, Washington, D.C, WA, USA, 20036

Website

https://www.60degreespharma.com

60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases through Arakoda and Celgosivir.